Metronidazole Noridem (Metronidazole)

Metronidazole Noridem is an antibiotic that targets anaerobic organisms and protozoa, making it useful for several infectious disease categories.

• Anaerobic bacterial infections: effective against mixed anaerobic infections, reducing bacterial load.
• Bacterial vaginosis: restores normal vaginal flora by eliminating over‑growth of anaerobes.
• Trichomoniasis: eradicates Trichomonas vaginalis, relieving symptoms and preventing recurrence.
• Amebic liver abscess: eliminates Entamoeba histolytica in hepatic tissue, aiding recovery.
• Clostridioides difficile infection: suppresses toxin‑producing C. difficile, helping resolve colitis.

• Metronidazole enters susceptible anaerobic cells and is reduced by microbial nitroreductases to generate nitro radical anions. These reactive intermediates damage DNA and other critical macromolecules, inhibiting nucleic acid synthesis and leading to cell death of anaerobic bacteria and protozoa.

Metronidazole Noridem may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Nausea: upset stomach often occurring shortly after infusion.
• Metallic taste: transient metallic sensation in the mouth.
• Headache: mild to moderate headache during or after treatment.
• Dizziness: occasional light‑headedness.
• Diarrhea: loose stools may appear.
• Abdominal pain: cramping or discomfort in the abdomen.

Serious or Rare Side Effects

• Seizures: rare neurologic events requiring immediate attention.
• Peripheral neuropathy: tingling or numbness in extremities.
• Severe allergic reaction (anaphylaxis): hives, swelling, breathing difficulty.
• Stevens‑Johnson syndrome: severe skin blistering and detachment.
• Hepatic toxicity: elevated liver enzymes or jaundice.
• Neutropenia: marked reduction in white blood cells.

Before using Metronidazole Noridem, consider the following safety measures.

• Renal impairment: adjust therapy in patients with reduced kidney function.
• Hepatic dysfunction: monitor liver enzymes and avoid in severe liver disease.
• Alcohol consumption: advise patients to avoid alcohol due to disulfiram‑like reaction.
• Pregnancy: use only if benefits outweigh potential risks; category unknown.
• Pediatric use: safety and efficacy not established in children.
• Store at ambient temperature: keep in original container, protect from moisture and light.

Metronidazole Noridem can interact with several medicines; some require avoidance while others need close monitoring.

Major Interactions (Avoid)

• Alcohol: may cause severe flushing, tachycardia, and hypotension.
• Warfarin: potentiates anticoagulant effect, increasing bleeding risk.
• Lithium: may raise lithium levels, leading to toxicity.
• Strong CYP450 inhibitors (e.g., cimetidine): increase metronidazole plasma concentrations.
• Live vaccines: risk of infection due to immunosuppression.

Moderate Interactions (Monitor Closely)

• Oral contraceptives: reduced efficacy, consider alternative contraception.
• Phenytoin: may lower metronidazole levels, reducing effectiveness.
• Carbamazepine: may decrease metronidazole concentrations, requiring dose adjustment.